Low Dose Tomosynthesis Compared to Traditional Tomosynthesis
NCT02771444 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2018-03-26
Summary
This study aims to evaluate image quality of a low-dose tomosynthesis system versus a comparator. Subjects will undergo a four-view tomosynthesis examination with the comparator and with the study device, and images will be assessed by several radiologists by comparing details in the images from the two systems.
Conditions
- Breast Neoplasms
Interventions
- DEVICE
-
Tomo Assessment
A four-view tomosynthesis examination
Sponsors & Collaborators
-
Philips Digital Mammography Sweden AB
lead INDUSTRY
Principal Investigators
-
Pietro Panizza, M.D · Ospedale San Raffaele
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2018-03-22
- Completion
- 2018-03-22
Countries
- Italy
Study Locations
More Related Trials
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
Automatized "Semi-Whole-Body"-MRI Protocol for Cancer Staging
NCT03648619 ·Status: TERMINATED ·Phase: NA
-
Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
NCT00775957 ·Status: TERMINATED
-
A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors
NCT03057509 ·Status: WITHDRAWN ·Phase: PHASE1
-
Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
NCT04016818 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
NCT01942759 ·Status: COMPLETED
-
Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects
NCT01362712 ·Status: TERMINATED ·Phase: PHASE1
-
Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients
NCT02755480 ·Status: TERMINATED ·Phase: NA
-
Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
NCT06774729 ·Status: RECRUITING
-
Evaluation of a Prototype Hand Held Hybrid Gamma Camera
NCT03920371 ·Status: COMPLETED ·Phase: NA
-
Nano MRI on 7 Tesla in Rectal and Breast Cancer
NCT02751606 ·Status: UNKNOWN ·Phase: PHASE3
-
PET/CT Evaluation of Treatment Response in Breast Cancer
NCT01222416 ·Status: TERMINATED ·Phase: NA
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma
NCT01827709 ·Status: TERMINATED ·Phase: NA
-
Imaging of in Vivo Sigma-2 Receptor Expression With 18F-ISO-1 Positron Emission Tomography in Metastatic Breast Cancer
NCT03057743 ·Status: TERMINATED
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
Positron Emission Tomography in Patients With Breast Cancer
NCT00001385 ·Status: COMPLETED
-
Imaging Multiparametric/Multimodality for Lungcancer
NCT02977663 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
NCT01224873 ·Status: UNKNOWN
-
Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer
NCT01012440 ·Status: TERMINATED ·Phase: NA
-
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
NCT02284919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
68Ga-MY6349 PET/CT in Solid Tumors
NCT07046702 ·Status: RECRUITING
-
Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
NCT02751710 ·Status: COMPLETED ·Phase: NA